Search Results - "KREIL, Sebastian"

Refine Results
  1. 1
  2. 2
  3. 3

    Multidrug‐resistant organisms in allogeneic hematopoietic cell transplantation by Heidenreich, Daniela, Kreil, Sebastian, Nolte, Florian, Hofmann, Wolf K., Miethke, Thomas, Klein, Stefan A.

    Published in European journal of haematology (01-05-2017)
    “…Objective Multidrug‐resistant organisms (MDRO) are a challenge in allogeneic hematopoietic cell transplantation (HCT). However, in the literature there is no…”
    Get full text
    Journal Article
  4. 4

    Somatic Diseases in Child Survivors of the Holocaust With Posttraumatic Stress Disorder: A Comparative Study by Sperling, Wolfgang, Kreil, Sebastian, Biermann, Teresa

    Published in The journal of nervous and mental disease (01-05-2012)
    “…ABSTRACTThe incidence of mental and somatic sequelae has been shown to be very high in people who survived the Holocaust. In the current study, 80 Holocaust…”
    Get full text
    Journal Article
  5. 5

    Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib by Ernst, Thomas, Erben, Philipp, Muller, Martin C, Paschka, Peter, Schenk, Thomas, Hoffmann, Jana, Kreil, Sebastian, La Rosee, Paul, Hehlmann, Rudiger, Hochhaus, Andreas

    Published in Haematologica (Roma) (01-02-2008)
    “…III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany Correspondence: Andreas Hochhaus, III. Medizinische…”
    Get full text
    Journal Article
  6. 6

    Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy by HANFSTEIN, Benjamin, MÜLLER, Martin C, KREIL, Sebastian, ERNST, Thomas, SCHENK, Thomas, LORENTZ, Christian, SCHWINDEL, Uwe, LEITNER, Armin, HEHLMANN, Rudiger, HOCHHAUS, Andreas

    Published in Haematologica (Roma) (01-03-2011)
    “…Point mutations of the BCR-ABL tyrosine kinase domain are considered the predominant cause of imatinib resistance in chronic myeloid leukemia. The expansion of…”
    Get full text
    Journal Article
  7. 7

    A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α by KREIL, Sebastian, WAGHORN, Katherine, ERNST, Thomas, CHASE, Andrew, WHITE, Helen, HEHLMANN, Rüdiger, REITER, Andreas, HOCHHAUS, Andreas, CROSS, Nicholas C. P

    Published in Haematologica (Roma) (01-01-2010)
    “…Interferon alpha (IFN) induces variable responses in chronic myeloid leukemia (CML), with 8-30% of early chronic phase cases achieving a complete cytogenetic…”
    Get full text
    Journal Article
  8. 8

    Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease by Degirmenci, Ümüt, Lewczuk, Piotr, Weih, Markus, Kuwert, Torsten, Kornhuber, Johannes, Schmidt, Daniela, Kreil, Sebastian

    “…SPECT allows registration of regional cerebral blood flow (rCBF) which is altered in a characteristic temporoparietal pattern in Alzheimer's Dementia. Numerous…”
    Get full text
    Journal Article
  9. 9

    Prospective analysis of the attendance behaviour of the participants of a facilitated support group for patients after allogeneic hematopoietic cell transplantation by Geeck, Karsten, Kreil, Sebastian, Hausmann, Michaela, Hofmann, Wolf-Karsten, Heidenreich, Daniela, Klein, Stefan A.

    Published in Supportive care in cancer (01-01-2024)
    “…Purpose Support groups might help survivors of allogeneic hematopoietic cell transplantations (HCT) to cope with medical, psychological, and social challenges…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms by Rotterdam, Jil, Thiaucourt, Margot, Schwaab, Juliana, Reiter, Andreas, Kreil, Sebastian, Steiner, Laurenz, Popp, Henning D., Hofmann, Wolf-Karsten, Bonatz, Karin, Gerhards, Catharina, Neumaier, Michael, Jawhar, Mohamad, Saussele, Susanne

    Published in Blood (23-11-2021)
    “…Background: In general, patients with hematological diseases are predisposed to develop infections. Severe COVID-19 infection associated with high mortality is…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    The insertion site is the main risk factor for central venous catheter‐related complications in patients with hematologic malignancies by Heidenreich, Daniela, Hansen, Eleonore, Kreil, Sebastian, Nolte, Florian, Jawhar, Mohamad, Hecht, Anna, Hofmann, Wolf‐Karsten, Klein, Stefan A.

    Published in American journal of hematology (01-03-2022)
    “…Central venous catheters (CVC) placed either via the internal jugular vein (IJV) or the subclavian vein (SCV) are routinely used in patients with hematologic…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis by Lübke, Johannes, Naumann, Nicole, Metzgeroth, Georgia, Kreil, Sebastian, Brand, Timo, Horny, Hans-Peter, Sotlar, Karl, Cross, Nicholas C. P., Fabarius, Alice, Valent, Peter, Hofmann, Wolf-Karsten, Reiter, Andreas, Schwaab, Juliana

    Published in Annals of hematology (01-08-2023)
    “…We sought to evaluate the efficacy of the purine analogue cladribine in 79 patients with advanced systemic mastocytosis (AdvSM) using data from the ‘German…”
    Get full text
    Journal Article